The Latest Cardiac and Vascular News
Leaders in business intelligence and the cardiovascular space use knowledge exchange and thought leadership in working towards better care and lower costs LUMEDX, a market leader in cardiovascular information systems (CVIS) and cutting-edge business intelligence solutions for more than 25 years, is excited to announce its industry partnership with MedAxiom, […]
Los Angeles, CA, Sept. 30, 2019 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”) today announces it has appointed Dr. William Li as Strategic Advisor to the CEO. Dr. Li and Endonovo CEO Alan Collier will work collaboratively and strategically to explore growth strategies for Endonovo’s […]
CALGARY, Alberta, Sept. 27, 2019 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX: RVX) today announces that it has issued a 10% secured convertible debenture in the principal amount of US$12 million (the “Debenture”) to a wholly-owned subsidiary of ORI Star Fund LP (“ORI” or the “Fund”). The […]
BEDFORD, Mass., Sept. 26, 2019 /PRNewswire/ — Access Vascular, a medical device company developing the next generation of intravenous devices from novel biomaterials designed to minimize the risk of bloodstream infection, catheter thrombosis, and vein trauma, announced $6M in new funding from new and existing investors. With this new round, Access Vascular is poised to […]
FRANKLIN LAKES, N.J., Sept. 26, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Vincent A. Forlenza, chairman and CEO, will retire as CEO on Jan. 28, 2020, following the company’s annual meeting of shareholders. Forlenza will continue on the BD board of directors, serving as […]
SANTA ANA, Calif.–(BUSINESS WIRE)–United Biologics, Inc., a global leader in silicone vasculature, today announced the appointment of John Barnhill as President and General Manager. As President and General Manager, Mr. Barnhill will guide the company’s commercial advancement and innovation strategies, as well as oversee all financial and operations infrastructure to […]
Led by ARTIS Ventures, Funding will Drive Further Research and Commercialization of Eko’s Machine Learning Platform San Francisco, CA, Sept. 25, 2019 (GLOBE NEWSWIRE) — Eko, a Silicon Valley-based digital health company building machine learning tools to fight heart disease, today announced it has secured $20 million in Series B funding. […]
Malmö, 25 September 2019 Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion The board of directors of Acarix AB (“Acarix” or the “Company”) has today, pursuant to the authorization granted by the extra general meeting on 16 August 2019, resolved to […]
Transaction to Create NASDAQ-Listed Rare and Specialty Disease Therapeutic Company Focused on Immunology and Metabolic Disorders $42.5M Concurrent Financing to be Led by a Syndicate of Healthcare Dedicated Investors Companies to Hold Conference Call on September 24th at 8:30AM EDT WALTHAM, Mass. and NEW YORK, Sept. 23, 2019 (GLOBE NEWSWIRE) — Proteon […]
LOS ANGELES–(BUSINESS WIRE)–Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, has entered into a financing agreement with Goldman Sachs Specialty Lending Group, L.P. (“Goldman Sachs”) involving the placement of Senior Secured Notes due 2024 pursuant to a committed purchase of up to $45 million, comprised […]
